FDA
-
-
-
-
-
-
-
SIGA Reports Financial Results for Three Months Ended March 31, 2024
-
-
-
-
-
-
-
SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
SIGA Technologies (SIGA) Appoints Jay K. Varma as EVP and Chief Medical Officer
-
-
-
-
-
-
-
SIGA Reports Financial Results for Three Months Ended March 31, 2023
-
-
-
-
-
-
-
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022
-
-
-
-
-
-
-
SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)
-
-
-
-
-
-
-
FDA Provides Update on Agency Response to Monkeypox Outbreak
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

